Theravance Biopharma, Inc. Stock, NASDAQ:TBPH
Ugland House, South Church Street, George Town, George Town KY1-1104
Number of Employees: 316
Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.